|
Median (IQR) or number of patients (%)
|
|---|
|
Group
|
RHYTHM B
|
|---|
|
Number
|
11
|
|
Age (IQR)
|
67 (19)
|
|
Male
|
9 (82)
|
|
Tumour stage (MRI)
|
|
T2
|
2 (18)
|
|
T3
|
9 (82)
|
|
T4
|
-
|
|
Nodal stage (MRI)
|
|
N0
|
4 (36)
|
|
N1
|
6 (55)
|
|
N2
|
1 (9)
|
|
Metastasis stage (CT)
|
|
M0
|
11 (100)
|
|
Differentiation
|
|
Well
|
1 (9)
|
|
Moderate
|
6 (55)
|
|
Poor
|
1 (9)
|
|
Not specified
|
3 (27)
|
|
Underwent TME
|
8 (73)
|
|
Response to CRTa
|
|
Good
|
5 (45)
|
|
Poor
|
6 (55)
|
-
IQR interquartile range, CRT chemoradiotherapy, % percentage, TME total mesorectal excision, CT computed tomography, MRI Magnetic resonance imaging, AJCC American Joint Committee on Cancer, TRG tumour regression grade
-
aGood response = AJCC TRG 0/1 with N0/1, or good clinical response; Poor response = AJCC TRG 2/3, N2 post-CRT or poor clinical response. One patient had delayed surgery due to initial good response, clinical outcome used
